Global Dry Powder Inhaler Device Market Insights and Forecast to 2028

Report ID: 1154584 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Dry Powder Inhaler Device Product Introduction
    1.2 Market by Type
        1.2.1 Global Dry Powder Inhaler Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Single Dose
        1.2.3 Multi Dose
    1.3 Market by Application
        1.3.1 Global Dry Powder Inhaler Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Asthma
        1.3.3 COPD
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Dry Powder Inhaler Device Sales Estimates and Forecasts 2017-2028
    2.2 Global Dry Powder Inhaler Device Revenue Estimates and Forecasts 2017-2028
    2.3 Global Dry Powder Inhaler Device Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Dry Powder Inhaler Device Sales by Region
        2.4.1 Global Dry Powder Inhaler Device Sales by Region (2017-2022)
        2.4.2 Global Sales Dry Powder Inhaler Device by Region (2023-2028)
    2.5 Global Dry Powder Inhaler Device Revenue by Region
        2.5.1 Global Dry Powder Inhaler Device Revenue by Region (2017-2022)
        2.5.2 Global Dry Powder Inhaler Device Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dry Powder Inhaler Device Sales by Manufacturers
        3.1.1 Global Top Dry Powder Inhaler Device Manufacturers by Sales (2017-2022)
        3.1.2 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dry Powder Inhaler Device in 2021
    3.2 Global Dry Powder Inhaler Device Revenue by Manufacturers
        3.2.1 Global Dry Powder Inhaler Device Revenue by Manufacturers (2017-2022)
        3.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Dry Powder Inhaler Device Revenue in 2021
    3.3 Global Dry Powder Inhaler Device Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dry Powder Inhaler Device Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Dry Powder Inhaler Device Sales by Type
        4.1.1 Global Dry Powder Inhaler Device Historical Sales by Type (2017-2022)
        4.1.2 Global Dry Powder Inhaler Device Forecasted Sales by Type (2023-2028)
        4.1.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    4.2 Global Dry Powder Inhaler Device Revenue by Type
        4.2.1 Global Dry Powder Inhaler Device Historical Revenue by Type (2017-2022)
        4.2.2 Global Dry Powder Inhaler Device Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    4.3 Global Dry Powder Inhaler Device Price by Type
        4.3.1 Global Dry Powder Inhaler Device Price by Type (2017-2022)
        4.3.2 Global Dry Powder Inhaler Device Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Dry Powder Inhaler Device Sales by Application
        5.1.1 Global Dry Powder Inhaler Device Historical Sales by Application (2017-2022)
        5.1.2 Global Dry Powder Inhaler Device Forecasted Sales by Application (2023-2028)
        5.1.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    5.2 Global Dry Powder Inhaler Device Revenue by Application
        5.2.1 Global Dry Powder Inhaler Device Historical Revenue by Application (2017-2022)
        5.2.2 Global Dry Powder Inhaler Device Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    5.3 Global Dry Powder Inhaler Device Price by Application
        5.3.1 Global Dry Powder Inhaler Device Price by Application (2017-2022)
        5.3.2 Global Dry Powder Inhaler Device Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Dry Powder Inhaler Device Market Size by Type
        6.1.1 North America Dry Powder Inhaler Device Sales by Type (2017-2028)
        6.1.2 North America Dry Powder Inhaler Device Revenue by Type (2017-2028)
    6.2 North America Dry Powder Inhaler Device Market Size by Application
        6.2.1 North America Dry Powder Inhaler Device Sales by Application (2017-2028)
        6.2.2 North America Dry Powder Inhaler Device Revenue by Application (2017-2028)
    6.3 North America Dry Powder Inhaler Device Market Size by Country
        6.3.1 North America Dry Powder Inhaler Device Sales by Country (2017-2028)
        6.3.2 North America Dry Powder Inhaler Device Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dry Powder Inhaler Device Market Size by Type
        7.1.1 Europe Dry Powder Inhaler Device Sales by Type (2017-2028)
        7.1.2 Europe Dry Powder Inhaler Device Revenue by Type (2017-2028)
    7.2 Europe Dry Powder Inhaler Device Market Size by Application
        7.2.1 Europe Dry Powder Inhaler Device Sales by Application (2017-2028)
        7.2.2 Europe Dry Powder Inhaler Device Revenue by Application (2017-2028)
    7.3 Europe Dry Powder Inhaler Device Market Size by Country
        7.3.1 Europe Dry Powder Inhaler Device Sales by Country (2017-2028)
        7.3.2 Europe Dry Powder Inhaler Device Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dry Powder Inhaler Device Market Size by Type
        8.1.1 Asia Pacific Dry Powder Inhaler Device Sales by Type (2017-2028)
        8.1.2 Asia Pacific Dry Powder Inhaler Device Revenue by Type (2017-2028)
    8.2 Asia Pacific Dry Powder Inhaler Device Market Size by Application
        8.2.1 Asia Pacific Dry Powder Inhaler Device Sales by Application (2017-2028)
        8.2.2 Asia Pacific Dry Powder Inhaler Device Revenue by Application (2017-2028)
    8.3 Asia Pacific Dry Powder Inhaler Device Market Size by Region
        8.3.1 Asia Pacific Dry Powder Inhaler Device Sales by Region (2017-2028)
        8.3.2 Asia Pacific Dry Powder Inhaler Device Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dry Powder Inhaler Device Market Size by Type
        9.1.1 Latin America Dry Powder Inhaler Device Sales by Type (2017-2028)
        9.1.2 Latin America Dry Powder Inhaler Device Revenue by Type (2017-2028)
    9.2 Latin America Dry Powder Inhaler Device Market Size by Application
        9.2.1 Latin America Dry Powder Inhaler Device Sales by Application (2017-2028)
        9.2.2 Latin America Dry Powder Inhaler Device Revenue by Application (2017-2028)
    9.3 Latin America Dry Powder Inhaler Device Market Size by Country
        9.3.1 Latin America Dry Powder Inhaler Device Sales by Country (2017-2028)
        9.3.2 Latin America Dry Powder Inhaler Device Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Type
        10.1.1 Middle East and Africa Dry Powder Inhaler Device Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Type (2017-2028)
    10.2 Middle East and Africa Dry Powder Inhaler Device Market Size by Application
        10.2.1 Middle East and Africa Dry Powder Inhaler Device Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Application (2017-2028)
    10.3 Middle East and Africa Dry Powder Inhaler Device Market Size by Country
        10.3.1 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Corporation Information
        11.2.2 AstraZeneca Overview
        11.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Corporation Information
        11.3.2 Boehringer Ingelheim Overview
        11.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Chiesi
        11.4.1 Chiesi Corporation Information
        11.4.2 Chiesi Overview
        11.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Chiesi Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Chiesi Recent Developments
    11.5 Cipla
        11.5.1 Cipla Corporation Information
        11.5.2 Cipla Overview
        11.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Cipla Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Cipla Recent Developments
    11.6 3M
        11.6.1 3M Corporation Information
        11.6.2 3M Overview
        11.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 3M Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 3M Recent Developments
    11.7 Hovione
        11.7.1 Hovione Corporation Information
        11.7.2 Hovione Overview
        11.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hovione Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hovione Recent Developments
    11.8 Mannkind
        11.8.1 Mannkind Corporation Information
        11.8.2 Mannkind Overview
        11.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Mannkind Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Mannkind Recent Developments
    11.9 Mylan
        11.9.1 Mylan Corporation Information
        11.9.2 Mylan Overview
        11.9.3 Mylan Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Mylan Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Mylan Recent Developments
    11.10 Novartis
        11.10.1 Novartis Corporation Information
        11.10.2 Novartis Overview
        11.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis Recent Developments
    11.11 Schering/Merck
        11.11.1 Schering/Merck Corporation Information
        11.11.2 Schering/Merck Overview
        11.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Schering/Merck Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Schering/Merck Recent Developments
    11.12 Teva
        11.12.1 Teva Corporation Information
        11.12.2 Teva Overview
        11.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Teva Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Teva Recent Developments
    11.13 Vectura
        11.13.1 Vectura Corporation Information
        11.13.2 Vectura Overview
        11.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Vectura Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Vectura Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Dry Powder Inhaler Device Industry Chain Analysis
    12.2 Dry Powder Inhaler Device Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dry Powder Inhaler Device Production Mode & Process
    12.4 Dry Powder Inhaler Device Sales and Marketing
        12.4.1 Dry Powder Inhaler Device Sales Channels
        12.4.2 Dry Powder Inhaler Device Distributors
    12.5 Dry Powder Inhaler Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dry Powder Inhaler Device Industry Trends
    13.2 Dry Powder Inhaler Device Market Drivers
    13.3 Dry Powder Inhaler Device Market Challenges
    13.4 Dry Powder Inhaler Device Market Restraints
14 Key Findings in The Global Dry Powder Inhaler Device Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Dry Powder Inhaler Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Single Dose
    Table 3. Major Manufacturers of Multi Dose
    Table 4. Global Dry Powder Inhaler Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Dry Powder Inhaler Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Dry Powder Inhaler Device Sales by Region (2017-2022) & (K Units)
    Table 7. Global Dry Powder Inhaler Device Sales Market Share by Region (2017-2022)
    Table 8. Global Dry Powder Inhaler Device Sales by Region (2023-2028) & (K Units)
    Table 9. Global Dry Powder Inhaler Device Sales Market Share by Region (2023-2028)
    Table 10. Global Dry Powder Inhaler Device Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Dry Powder Inhaler Device Revenue Market Share by Region (2017-2022)
    Table 12. Global Dry Powder Inhaler Device Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Dry Powder Inhaler Device Revenue Market Share by Region (2023-2028)
    Table 14. Global Dry Powder Inhaler Device Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Dry Powder Inhaler Device Sales Share by Manufacturers (2017-2022)
    Table 16. Global Dry Powder Inhaler Device Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2017-2022)
    Table 18. Dry Powder Inhaler Device Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Dry Powder Inhaler Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhaler Device as of 2021)
    Table 21. Dry Powder Inhaler Device Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Dry Powder Inhaler Device Product Offered
    Table 23. Date of Manufacturers Enter into Dry Powder Inhaler Device Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 26. Global Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 27. Global Dry Powder Inhaler Device Sales Share by Type (2017-2022)
    Table 28. Global Dry Powder Inhaler Device Sales Share by Type (2023-2028)
    Table 29. Global Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Dry Powder Inhaler Device Revenue Share by Type (2017-2022)
    Table 32. Global Dry Powder Inhaler Device Revenue Share by Type (2023-2028)
    Table 33. Dry Powder Inhaler Device Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Dry Powder Inhaler Device Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 36. Global Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 37. Global Dry Powder Inhaler Device Sales Share by Application (2017-2022)
    Table 38. Global Dry Powder Inhaler Device Sales Share by Application (2023-2028)
    Table 39. Global Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Dry Powder Inhaler Device Revenue Share by Application (2017-2022)
    Table 42. Global Dry Powder Inhaler Device Revenue Share by Application (2023-2028)
    Table 43. Dry Powder Inhaler Device Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Dry Powder Inhaler Device Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 46. North America Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 47. North America Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 50. North America Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 51. North America Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
    Table 54. North America Dry Powder Inhaler Device Sales by Country (2023-2028) & (K Units)
    Table 55. North America Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Dry Powder Inhaler Device Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Dry Powder Inhaler Device Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Dry Powder Inhaler Device Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Dry Powder Inhaler Device Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Dry Powder Inhaler Device Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Dry Powder Inhaler Device Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Dry Powder Inhaler Device Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Dry Powder Inhaler Device Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Dry Powder Inhaler Device Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Dry Powder Inhaler Device Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Dry Powder Inhaler Device Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Dry Powder Inhaler Device Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Dry Powder Inhaler Device Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Dry Powder Inhaler Device Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GlaxoSmithKline Corporation Information
    Table 106. GlaxoSmithKline Description and Major Businesses
    Table 107. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. GlaxoSmithKline Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GlaxoSmithKline Recent Developments
    Table 110. AstraZeneca Corporation Information
    Table 111. AstraZeneca Description and Major Businesses
    Table 112. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. AstraZeneca Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. AstraZeneca Recent Developments
    Table 115. Boehringer Ingelheim Corporation Information
    Table 116. Boehringer Ingelheim Description and Major Businesses
    Table 117. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Boehringer Ingelheim Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Boehringer Ingelheim Recent Developments
    Table 120. Chiesi Corporation Information
    Table 121. Chiesi Description and Major Businesses
    Table 122. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Chiesi Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Chiesi Recent Developments
    Table 125. Cipla Corporation Information
    Table 126. Cipla Description and Major Businesses
    Table 127. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Cipla Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Cipla Recent Developments
    Table 130. 3M Corporation Information
    Table 131. 3M Description and Major Businesses
    Table 132. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. 3M Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. 3M Recent Developments
    Table 135. Hovione Corporation Information
    Table 136. Hovione Description and Major Businesses
    Table 137. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Hovione Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Hovione Recent Developments
    Table 140. Mannkind Corporation Information
    Table 141. Mannkind Description and Major Businesses
    Table 142. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Mannkind Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Mannkind Recent Developments
    Table 145. Mylan Corporation Information
    Table 146. Mylan Description and Major Businesses
    Table 147. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Mylan Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Mylan Recent Developments
    Table 150. Novartis Corporation Information
    Table 151. Novartis Description and Major Businesses
    Table 152. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Novartis Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Novartis Recent Developments
    Table 155. Schering/Merck Corporation Information
    Table 156. Schering/Merck Description and Major Businesses
    Table 157. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Schering/Merck Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Schering/Merck Recent Developments
    Table 160. Teva Corporation Information
    Table 161. Teva Description and Major Businesses
    Table 162. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Teva Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Teva Recent Developments
    Table 165. Vectura Corporation Information
    Table 166. Vectura Description and Major Businesses
    Table 167. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 168. Vectura Dry Powder Inhaler Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Vectura Recent Developments
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Dry Powder Inhaler Device Distributors List
    Table 173. Dry Powder Inhaler Device Customers List
    Table 174. Dry Powder Inhaler Device Market Trends
    Table 175. Dry Powder Inhaler Device Market Drivers
    Table 176. Dry Powder Inhaler Device Market Challenges
    Table 177. Dry Powder Inhaler Device Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dry Powder Inhaler Device Product Picture
    Figure 3. Global Dry Powder Inhaler Device Market Share by Type in 2021 & 2028
    Figure 3. Single Dose Product Picture
    Figure 4. Multi Dose Product Picture
    Figure 5. Global Dry Powder Inhaler Device Market Share by Application in 2021 & 2028
    Figure 6. Asthma
    Figure 7. COPD
    Figure 8. Others
    Figure 9. Dry Powder Inhaler Device Report Years Considered
    Figure 10. Global Dry Powder Inhaler Device Sales 2017-2028 (K Units)
    Figure 11. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Dry Powder Inhaler Device Revenue 2017-2028 (US$ Million)
    Figure 13. Global Dry Powder Inhaler Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Dry Powder Inhaler Device Sales Market Share by Region (2017-2022)
    Figure 15. Global Dry Powder Inhaler Device Sales Market Share by Region (2023-2028)
    Figure 16. North America Dry Powder Inhaler Device Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Dry Powder Inhaler Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Dry Powder Inhaler Device Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Dry Powder Inhaler Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Dry Powder Inhaler Device Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Dry Powder Inhaler Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Dry Powder Inhaler Device Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Dry Powder Inhaler Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Dry Powder Inhaler Device Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Dry Powder Inhaler Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Dry Powder Inhaler Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Dry Powder Inhaler Device in the World: Market Share by Dry Powder Inhaler Device Revenue in 2021
    Figure 28. Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 30. Global Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 31. Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 32. Global Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 33. North America Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 34. North America Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 35. North America Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 36. North America Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 37. North America Dry Powder Inhaler Device Sales Share by Country (2017-2028)
    Figure 38. North America Dry Powder Inhaler Device Revenue Share by Country (2017-2028)
    Figure 39. U.S. Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 42. Europe Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 44. Europe Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Dry Powder Inhaler Device Sales Share by Country (2017-2028)
    Figure 46. Europe Dry Powder Inhaler Device Revenue Share by Country (2017-2028)
    Figure 47. Germany Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 48. France Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Dry Powder Inhaler Device Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Dry Powder Inhaler Device Revenue Share by Region (2017-2028)
    Figure 58. China Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 61. India Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Dry Powder Inhaler Device Sales Share by Country (2017-2028)
    Figure 73. Latin America Dry Powder Inhaler Device Revenue Share by Country (2017-2028)
    Figure 74. Mexico Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Dry Powder Inhaler Device Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Dry Powder Inhaler Device Revenue Share by Country (2017-2028)
    Figure 83. Turkey Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Dry Powder Inhaler Device Revenue (2017-2028) & (US$ Million)
    Figure 86. Dry Powder Inhaler Device Value Chain
    Figure 87. Dry Powder Inhaler Device Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Frequently Asked Questions
Dry Powder Inhaler Device report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dry Powder Inhaler Device report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dry Powder Inhaler Device report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Kirschner Wires

Kirschner Wires market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

LED Thermal Products

LED Thermal Products market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Nuclear Medicine

Nuclear Medicine market is segmented by players, region (country), by Type and by Application. Pl ... Read More